Decoy Therapeutics is trading at $3.12 (+15.07%) after closing at $2.71 on September 14, with no confirmed announcement directly explaining the pre-market move.

  • A special shareholder meeting addressed warrant issuance and authorized shares.
  • The company said final voting results would be filed within four business days.